This page is part of the HL7 FHIR Implementation Guide: minimal Common Oncology Data Elements (mCODE) Release 1 - US Realm | STU1 (v1.0.0: STU 1) based on FHIR R4. The current version which supercedes this version is 2.0.0. For a full list of available versions, see the Directory of published versions

Cancer Disease Status Evidence Type Value Set

Summary

Defining URL:	http://hl7.org/fhir/us/mcode/ValueSet/mcode-cancer-disease-status-evidence-type-vs
Version:	1.0.0
Name:	CancerDiseaseStatusEvidenceTypeVS
Status:	Active
Title:	Cancer Disease Status Evidence Type Value Set
Definition:	The type of evidence backing up the clinical determination of cancer progression. The code '* SCT#252416005 Histopathology test (procedure)' is intended to be used when there is a biopsy that contributes evidence of the cancer disease status.
Publisher:	HL7 International Clinical Interoperability Council
Source Resource:	XML / JSON / Turtle

References

• Cancer Disease Status

Content Logical Definition

Definition

 

Expansion

---

Explanation of the columns that may appear on this page:

Level	A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
Source	The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code	The code (used as the code in the resource instance)
Display	The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition	An explanation of the meaning of the concept
Comments	Additional notes about how to use the code